- Home
- AZN vs TD Comparison
AZN vs TD Comparison
Compare AZN & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AZN | TD |
|---|---|---|
| Founded | 1992 | 1855 |
| Country | United Kingdom | Canada |
| Employees | 96100 | 70000 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.4B | 152.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AZN | TD |
|---|---|---|
| Price | $200.42 | $104.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $120.00 |
| AVG Volume (30 Days) | 1.8M | ★ 2.6M |
| Earning Date | 04-29-2026 | 05-21-2026 |
| Dividend Yield | 1.59% | ★ 2.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.35 | N/A |
| Revenue Next Year | $6.43 | $4.48 |
| P/E Ratio | $31.91 | ★ $11.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.16 | $60.47 |
| 52 Week High | $212.71 | $104.08 |
Technical Indicators
Market Signals| Indicator | AZN | TD |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 74.83 |
| Support Level | $182.39 | $92.13 |
| Resistance Level | $211.32 | N/A |
| Average True Range (ATR) | 3.46 | 1.40 |
| MACD | -0.20 | 1.09 |
| Stochastic Oscillator | 63.97 | 98.51 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.